BioSpace News Archive

BioCapital

Samsung Offers $3 Million to U.S. Public Schools Who Use STEM to “Solve for Tomorrow”

The 10th Annual Samsung Solve for Tomorrow Contest empowers thousands of students to create innovative solutions that transform local communities

September 12, 2019
·
7 min read
Business

Expanding Reach Across US, Three New Members Join the National Alliance of Healthcare Purchaser Coalitions

These organization serve as leaders in their cities, counties, states and regions and are involved in education and networking, community collaboration, quality improvement and public reporting efforts.

September 12, 2019
·
4 min read
FDA

Ardelyx Receives FDA Approval for IBSRELA® (Tenapanor), an NHE3 Sodium Transport Inhibitor, for the Treatment of Irritable Bowel Syndrome with Constipation

Ardelyx, Inc. announced that the U.S. Food and Drug Administration has approved IBSRELA®, a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation in adults.

September 12, 2019
·
10 min read
Imfinzi® (durvalumab) is the First Immunotherapy to Show Both Significant Survival Benefit and Improved, Durable Responses in Extensive-Stage Small Cell Lung Cancer

Data presented at the IASLC 2019 World Conference on Lung Cancer demonstrated the Phase III CASPIAN trial of Imfinzi improved survival with either a cisplatin or carboplatin chemotherapy backbone

September 12, 2019
·
6 min read
Biotech Beach

Hyundai Hope On Wheels Presents UCLA Mattel Children’s Hospital With Hyundai Young Investigator And Scholar Hope Grant Totaling $500,000 To Support Pediatric Cancer Research

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [12-September-2019] LOS ANGELES , Sept. 12, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported b

September 12, 2019
·
4 min read
Policy

Napoli Shkolnik PLLC Files Groundbreaking Class Action Lawsuit Against United Behavioral Health on Behalf of Providers

Filed in the United States District Court for the Northern District of California, the class action complaint alleges that the nation’s largest health insurer, United Behavioral Health, wrongfully denied mental health and substance use disorder claims by putting profits over patients.

September 12, 2019
·
2 min read
Business

ViewRay Announces Collaboration with Stanford Health Care

Stanford Health Care to Acquire a ViewRay MRIdian System

September 12, 2019
·
1 min read
Policy

AARC Supports Administration’s Decision to Remove Flavored E-Cigarettes from the Market

The American Association for Respiratory Care strongly supports the Administration’s announcement on September 11 regarding its plans to remove flavored e-cigarettes from the marketplace and commends its actions to protect our nation’s youth from being deceived by the tobacco industry’s marketing strategies that have led to the current epidemic of youth e-cigarette and vaping use.

September 12, 2019
·
2 min read
Drug Development

Celgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints

Celgene Corporation announced top-line results from the international phase 3, randomized, double-blind, placebo-controlled study, QUAZAR AML-001.

September 12, 2019
·
5 min read
FDA

Qfix® Announces FDA 510(k) Clearance of Encompass™ 15 Channel Head Coil for Siemens 3T MRI Systems

Qfix has received FDA 510 clearance for the Encompass 15-Channel Head Coil, a diagnostic imaging device optimized for use with the Encompass™ MR SRS Immobilization Device.

September 12, 2019
·
1 min read